M. González Martín

HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

J A Martínez-Piñeiro, Luis Martínez‐Piñeiro, Eduardo Solsona et al. · The Journal of Urology · 2005 · 192 citations

Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III Study

J A Martínez-Piñeiro, M. González Martín, Fernando Arocena et al. · The Journal of Urology · 1995 · 162 citations

Surgical Oncology, Adjuvant Chemotherapy, Surgery +16

Prophylactic growth factor (GF) support with adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-negative breast cancer (BC): An interim safety analysis of the GEICAM 9805 study

M. González Martín, Aňa Lluch, Miguel Ángel Seguí et al. · Journal of Clinical Oncology · 2004 · 24 citations

Surgical Oncology, Breast Oncology, Prognosis +24

Multicenter, randomized phase III study of adjuvant chemotherapy for high-risk, node-negative breast cancer comparing tac with fac: 5-year efficacy analysis of the GEICAM 9805 trial

M. González Martín, A. Iluch, Miguel Ángel Seguí et al. · Journal of Clinical Oncology · 2008 · 14 citations

Surgical Oncology, Breast Oncology, Adjuvant Chemotherapy +19

[Spontaneous thrombosis of left varicocele].

F. Kleinclauss, Emmanuel Della Negra, M. González Martín et al. · PubMed · 2001 · 13 citations